Exhibit 10.1
Execution Version
STOCK PURCHASE AGREEMENT
by and among
NOBLE TUBE TECHNOLOGIES,
LLC
(“Buyer”),
NOBLE INTERNATIONAL, LTD.
(“Noble”),
and
THE SHAREHOLDERS OF
PULLMAN INDUSTRIES, INC.
(“Sellers”)
October 12, 2006
TABLE OF
CONTENTS
|
|
|
|
|
|
|
ARTICLE 1 PRINCIPAL TRANSACTION
|
|
1
|
|
|
|
|
|
Section 1.1.
|
|
Sale and
Purchase of Stock
|
|
1
|
|
Section 1.2.
|
|
Purchase Price;
Payment
|
|
1
|
|
Section 1.3.
|
|
Adjustments to
Purchase Price
|
|
2
|
|
Section 1.4.
|
|
Closing.
|
|
5
|
|
Section 1.5.
|
|
Deliveries at
the Closing
|
|
5
|
|
|
|
|
ARTICLE 2 REPRESENTATIONS AND WARRANTIES OF
SELLERS
|
|
7
|
|
|
|
|
|
Section 2.1.
|
|
Organization;
Capitalization; Ownership
|
|
7
|
|
Section 2.2.
|
|
Financial
Statements and Financial Matters
|
|
8
|
|
Section 2.3.
|
|
Books and
Records
|
|
10
|
|
Section 2.4.
|
|
Taxes
|
|
10
|
|
Section 2.5.
|
|
Business
Operations
|
|
11
|
|
Section 2.6.
|
|
Employees
|
|
13
|
|
Section 2.7.
|
|
Employee
Benefit Plans
|
|
14
|
|
Section 2.8.
|
|
Real
Property
|
|
16
|
|
Section 2.9.
|
|
Other
Properties and Assets
|
|
17
|
|
Section 2.10.
|
|
Litigation
|
|
18
|
|
Section 2.11.
|
|
Authorization
and Enforceability; No Conflict
|
|
18
|
|
Section 2.12.
|
|
Applicable
Contracts; Insurance
|
|
19
|
|
Section 2.13.
|
|
Permits and
Licenses; Compliance with Legal Requirements
|
|
20
|
|
Section 2.14.
|
|
Environmental
Matters
|
|
21
|
|
Section 2.15.
|
|
No
Broker’s Fees
|
|
22
|
|
Section 2.16.
|
|
Accuracy of
Information
|
|
22
|
|
Section 2.17.
|
|
Mexican
Subsidiary Representations
|
|
22
|
|
|
|
|
ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF
BUYER AND NOBLE
|
|
24
|
|
|
|
|
|
Section 3.1.
|
|
Organization
and Good Standing
|
|
24
|
|
Section 3.2.
|
|
Authorization
and Enforceability; No Conflict
|
|
24
|
|
Section 3.3.
|
|
Investment
Intent
|
|
24
|
|
Section 3.4.
|
|
No
Broker’s Fees
|
|
24
|
|
Section 3.5.
|
|
Purpose of
Transaction
|
|
25
|
|
|
|
|
ARTICLE 4 COVENANTS AND AGREEMENTS
|
|
25
|
|
|
|
|
|
Section 4.1.
|
|
Further
Assurances
|
|
25
|
|
Section 4.2.
|
|
Restrictive
Covenants
|
|
25
|
|
Section 4.3.
|
|
Public
Announcements
|
|
26
|
|
Section 4.4.
|
|
Sellers
Representative
|
|
26
|
|
Section 4.5.
|
|
Discharge of
Related Party Fees
|
|
29
|
|
Section 4.6.
|
|
Title
Insurance
|
|
29
|
|
Section 4.7.
|
|
Parent
Guarantee
|
|
29
|
|
Section 4.8.
|
|
Right of First
Refusal
|
|
29
|
|
Section 4.9.
|
|
Transition of
Bloomingdale Warehouse
|
|
29
|
-i-
|
|
|
|
|
|
|
Section 4.10.
|
|
Termination of
Certain Agreements.
|
|
30
|
|
Section 4.11.
|
|
Stock
Purchase
|
|
30
|
|
Section 4.12.
|
|
Tax Returns and
Related Matters.
|
|
30
|
|
Section 4.13.
|
|
Closing Books
for Tax Purposes
|
|
32
|
|
Section 4.14.
|
|
Interest Charge
DISC Subsidiary.
|
|
33
|
|
Section 4.15.
|
|
Mexican and
Swiss Taxes.
|
|
33
|
|
Section 4.16.
|
|
IP Tax
Matters.
|
|
33
|
|
Section 4.17.
|
|
Post-Retirement
Benefits.
|
|
34
|
|
|
|
|
ARTICLE 5 INDEMNIFICATION
|
|
34
|
|
|
|
|
|
Section 5.1.
|
|
Indemnification
and Reimbursement by Sellers
|
|
34
|
|
Section 5.2.
|
|
Indemnification
and Reimbursement by Buyer
|
|
34
|
|
Section 5.3.
|
|
De Minimis
Claims; Basket; Cap; Bloomingdale Environmental Limits.
|
|
34
|
|
Section 5.4.
|
|
Indemnification
Procedures
|
|
35
|
|
Section 5.5.
|
|
Offset
|
|
37
|
|
Section 5.6.
|
|
Adjusted
Purchase Price; Interest
|
|
37
|
|
Section 5.7.
|
|
Determination
of Adverse Consequences; Indemnification Limitations
|
|
37
|
|
Section 5.8.
|
|
Exclusive
Remedy
|
|
38
|
|
Section 5.9.
|
|
Tax
Claims
|
|
38
|
|
|
|
|
ARTICLE 6 DEFINITIONS
|
|
40
|
|
|
|
|
ARTICLE 7 GENERAL
|
|
51
|
|
|
|
|
|
Section 7.1.
|
|
Survival of
Representations, Warranties, Covenants and Agreements
|
|
51
|
|
Section 7.2.
|
|
Binding Effect;
Benefits; Assignment
|
|
51
|
|
Section 7.3.
|
|
Entire
Agreement
|
|
52
|
|
Section 7.4.
|
|
Amendment and
Waiver
|
|
52
|
|
Section 7.5.
|
|
Governing
Law
|
|
52
|
|
Section 7.6.
|
|
Notices
|
|
52
|
|
Section 7.7.
|
|
Counterparts
|
|
53
|
|
Section 7.8.
|
|
Expenses
|
|
53
|
|
Section 7.9.
|
|
Headings;
Construction; Time of Essence
|
|
53
|
|
Section 7.10.
|
|
Partial
Invalidity
|
|
54
|
|
Section 7.11.
|
|
Waiver of Jury
Trial
|
|
54
|
-ii-
|
|
|
|
|
Exhibit 1.2(b)
|
|
Overdue
Accounts Receivable
|
|
Exhibit 1.2(c)
|
|
Deferred
Payment Amount Terms
|
|
Exhibit 1.3(b)
|
|
Estimated
Closing Date Net Working Capital
|
|
Exhibit 1.5(b)(v)
|
|
Form of Legal
Opinion of Honigman Miller Schwartz and Cohn LLP
|
|
Exhibit 1.5(b)(viii)
|
|
Form of Payoff
Letter
|
|
Exhibit 4.5
|
|
Accounts
Receivable and Payable
|
|
Exhibit 4.13
|
|
Tax
Form
|
|
Exhibit 4.14
|
|
IC-DISC, Inc.
Transactions
|
|
Exhibit 5.1
|
|
Specific
Indemnification Matters
|
|
Exhibit 8.1
|
|
Permitted
Encumbrances
|
|
Exhibit 8.2
|
|
September 30,
2006 Balance Sheet
|
|
Exhibit 8.3
|
|
Sellers’
Knowledge Parties
|
-iii-
STOCK PURCHASE
AGREEMENT
THIS STOCK PURCHASE AGREEMENT (the
“Agreement”) is made as of October 12, 2006, by and
among NOBLE TUBE TECHNOLOGIES, LLC, a Michigan limited liability
company (“Buyer”), NOBLE INTERNATIONAL, LTD., a
Delaware corporation (“Noble”), and each shareholder
(each a “Seller” and collectively
“Sellers”) of Pullman Industries, Inc., a Michigan
corporation (the “Company”). Buyer, Noble and Sellers
are sometimes individually referred to in this Agreement as a
“Party” and collectively as the “Parties.”
Other capitalized terms used in this Agreement and not otherwise
defined are defined in Article 6 .
The Company and the Subsidiaries are
engaged in the business of manufacturing and selling products
utilizing the roll forming and/or stretch bending process in the
automotive and office furniture markets (the
“Business”). Buyer desires to purchase from Sellers,
and Sellers desire to sell to Buyer, all of the outstanding capital
stock of the Company on the terms and subject to the conditions of
this Agreement. Noble joins in this Agreement to guaranty
Buyer’s performance pursuant to the terms of this
Agreement.
ACCORDINGLY, in consideration of the
representations, warranties, covenants and agreements contained in
this Agreement, the Parties agree as follows:
ARTICLE 1
PRINCIPAL
TRANSACTION
Section 1.1. Sale and
Purchase of Stock . On
the terms and subject to the conditions of this Agreement, Sellers
agree to sell and transfer to Buyer, and Buyer agrees to purchase
from Sellers, all of the issued and outstanding shares of capital
stock of the Company, consisting of 6,000,000 shares of common
stock, no par value per share (the “Shares”), free and
clear of all Encumbrances.
Section 1.2. Purchase Price;
Payment .
(a) Subject to adjustment under
Section 1.3 , if applicable, in consideration of the
transfer of the Shares to Buyer and the other undertakings of
Sellers set forth in this Agreement, Buyer agrees to pay to
Sellers, in the aggregate, the sum of (i) $49,976,000 plus
(ii) the Deferred Payment Amount, plus (iii) the Tax
Refund Amount (in the aggregate, as adjusted, the “Purchase
Price”).
(b) Subject to adjustment under
Section 1.3 , if applicable, $42,476,000 of the
Purchase Price (the “Initial Payment”) will be paid to
Sellers at Closing by wire transfer of immediately available funds
to an account designated by Sellers Representative, and $7,500,000
of the Purchase Price will be paid into escrow pending (i) the
collection by the Company or a Subsidiary of those accounts
receivable set forth on Exhibit 1.2(b) (estimated by Sellers
not to exceed $257,724), and (ii) resolution of any claims for
indemnification that may be made by Buyer under Article 5
during the stated duration of the escrow, as more fully set forth
in the escrow agreement (the “Escrow
Agreement”).
1
(c) The Deferred Payment Amount,
which will not exceed $14,000,000 in the aggregate, will be paid to
Sellers within 10 days after each month end in which any Deferred
Payment Amount due Sellers hereunder is received by wire transfer
of immediately available funds to an account designated by Sellers
Representative, subject to satisfaction of the payment conditions
set forth on Exhibit 1.2(c) . Buyer shall use commercially
reasonable efforts in good faith to collect the payments indicated
on Exhibit 1.2(c) (the “Tooling Receivables”)
according to the schedule indicated therein, but will not be
required to commence any Proceeding, utilize any collection or
similar agency, or cease doing business with any applicable account
debtor. In connection with the collection of the Tooling
Receivables, Buyer will not reduce or otherwise compromise any
Tooling Receivable in exchange for, or to influence an account
debtor to give, any concession or other accommodation to Buyer or
any of its Affiliates that is unrelated to the applicable Tooling
Receivable, and Buyer will not be required to grant any concession
or other accommodation to collect any Tooling Receivable. Buyer
will provide Sellers Representative with a monthly status report of
Tooling Receivables collections. If Tooling Receivables are not
collected within 60 days of the applicable invoice date, Sellers
Representative or his or her designee will have the opportunity to
discuss and review a summary of the efforts of Buyer to obtain
payment of the outstanding Tooling Receivables and may participate
in joint discussions and other communications with Buyer and the
applicable account debtor; provided , however , that
Buyer may reasonably limit the scope of such communications if
Buyer believes that such communications would be reasonably likely
to adversely affect the customer relationship between Buyer and the
applicable account debtor; and provided , further ,
that Sellers Representative or his or her designee must conduct
himself or herself in such a manner as to not adversely affect the
customer relationship between Buyer and the applicable account
debtor.
(d) One half of any Tax Refund
Amount will be paid to Sellers within three business days following
receipt by the Company of such Tax Refund Amount, by wire transfer
of immediately available funds to an account designated by Sellers
Representative. Buyer will promptly notify Sellers of receipt of
any Tax Refund Amount. Any Tax Refund Amount payable to Sellers
under this Section 1.2(d) not paid when due will bear
interest at 12% per annum from the date such amount is
required to be paid hereunder until paid, increasing to
15% per annum from and after 30 days of the due date and
increasing to 18% per annum from and after 60 days of the date
due.
Section 1.3. Adjustments to
Purchase Price .
(a) On October 2, 2006, Sellers
delivered to Buyer their good faith estimate of the U.S. Closing
Date Debt, which was estimated by Sellers to be $44,339,385, and
the Mexican Closing Date Debt, which was estimated by Sellers to be
$21,347,825.
(b) The Initial Payment will be
decreased on a dollar-for-dollar basis to the extent that the
Closing Date U.S. Net Working Capital is less than $10,000,000.
Sellers have estimated Closing Date U.S. Net Working Capital to be
$10,164,820, as calculated on Exhibit 1.3(b) .
(c) Within 30 days after the Closing
Date, Buyer will cause to be prepared and delivered to Sellers
Representative (i) an itemized calculation (each a
“Closing Date Debt Statement” and collectively, the
“Closing Date Debt Statements”) of actual Closing Date
Debt of the Company and the U.S. Subsidiaries and the Mexican
Subsidiaries, exclusive of debt owed by
2
WLP Properties S. de R.L. de C.V. to TMW
Enterprises de Juarez, S.A. de C.V., TMW Enterprises de Mexico,
S.A. de C.V. and TMW Enterprises de Torreon, S.A. de C.V. not in
excess of an aggregate amount of $1,200,000 (the “Mexican
Closing Date Debt”), and (ii) an itemized calculation of
Closing Date U.S. Net Working Capital (the “Closing Date U.S.
Net Working Capital Statement”). Sellers will have the
opportunity to review the Closing Date Debt Statements and the
Closing Date U.S. Net Working Capital Statement for 20 days
following receipt thereof (the “Review Period”). During
the Review Period, Buyer and its Representatives will provide to
Sellers and their Representatives access to all information to
enable Sellers and their Representatives to review and evaluate the
Closing Date Debt Statements and the Closing Date U.S. Net Working
Capital Statement. Each of the applicable Closing Date Debt
Statements and the Closing Date U.S. Net Working Capital Statement
will become final, conclusive and binding on Sellers unless, prior
to the end of the Review Period, Sellers Representative notifies
Buyer in writing of Sellers’ objections to the Closing Date
Debt Statement and/or the Closing Date U.S. Net Working Capital
Statement, identifying the disputed items, the estimated amounts of
the disputed items if then calculable and the basic facts
underlying Sellers’ objections. If Sellers Representative
gives such an objection notice, the Parties will try in good faith
to resolve the objections within 30 days. If the Parties resolve
some or all of the objections within that time period, they will
promptly record their resolution in a writing signed by each of
them, and such resolution will be final, conclusive and binding on
each of them. If the Parties are unable to resolve all of the
objections within the 30-day time period, they will promptly refer
any matters still in dispute for resolution as provided in
Section 1.3(g) . Each Closing Date Debt Statement, in
the form that is final, conclusive and binding on the Parties
hereunder, is referred to as the “Final Closing Date Debt
Statement” and, collectively as the “Final Closing Date
Debt Statements”. The Closing Date U.S. Net Working Capital
Statement, in the form that is final, conclusive and binding on the
Parties hereunder, is referred to as the “Final Closing Date
U.S. Net Working Capital Statement”.
(d) The Purchase Price will be
decreased on a dollar-for-dollar basis to the extent that the U.S.
Closing Date Debt as reflected on the applicable Final Closing Date
Debt Statement is greater than the Maximum U.S. Debt. The Purchase
Price will also be decreased on a dollar-for-dollar basis to the
extent that the Mexican Closing Date Debt as reflected on the
applicable Final Closing Date Debt Statement is greater than
$21,347,825. Any decrease in the Purchase Price pursuant to this
Section 1.3(d) will be paid by Sellers to Buyer within
seven days following the date the applicable Final Closing Date
Debt Statement becomes final, conclusive and binding, together with
interest thereon at 8% per annum from the Closing Date until
paid; provided , however , that any amount not timely
paid under this Section 1.3(d) will bear interest at
12% per annum from and after the date such amount is required
to be paid hereunder until paid, increasing to 15% per annum
from and after 30 days of the date due and increasing to
18% per annum from and after 60 days of the date
due.
(e) If the Closing Date U.S. Net
Working Capital as reflected on the Final Closing Date U.S. Net
Working Capital Statement is less than $10,000,000, Sellers will
pay the amount of such deficiency to Buyer within seven days
following the date that the Final Closing Date U.S. Net Working
Capital Statement becomes final, conclusive and binding, together
with interest thereon at 8% per annum from the Closing Date
until paid; provided , however , that any amount not
timely paid under this Section 1.3(e) will bear
interest at 12% per annum from and after the date such amount
is required to be paid hereunder until paid, increasing to
15% per annum from and after 30 days of the date due and
increasing to 18% per annum from and after 60 days of the date
due.
3
(f) If Sellers fail to pay any
amount owed under this Section 1.3 in a timely manner,
in addition to any other remedies that Buyer may have under
applicable Legal Requirements or this Agreement (including
commencing a Proceeding for indemnification) (i) Buyer may
withdraw from the escrow fund under the Escrow Agreement the dollar
amount owed to it under this Section 1.3 , without any
right of Sellers or Sellers Representative to object to such
withdrawal and neither Sellers nor Sellers Representative will
object to such withdrawal and (ii) Sellers will, within three
business days of such withdrawal, transfer to the escrow fund held
under the Escrow Agreement the amount of such withdrawal. Any
amount not timely paid into the escrow fund under this
Section 1.3(f) will bear interest thereon at
12% per annum from the date such amount is required to be paid
hereunder until paid, increasing to 15% per annum from and
after 30 days of the date due and increasing to 18% per annum
from and after 60 days of the date due.
(g) Any unresolved dispute under
Section 1.3(c) above will be promptly referred for
resolution to the Detroit office of the Transaction Services Group
of Ernst & Young LLP who will be jointly retained by the
Parties. If the Parties are unable to engage Ernst & Young
LLP for any reason, or Ernst & Young LLP is no longer
independent at the time a dispute is submitted to it, then Buyer
and Sellers Representative will each designate a nationally or
regionally recognized independent accounting firm with whom neither
they nor any of their respective Affiliates has any current
professional relationship, and the accounting firm to resolve the
dispute will be chosen by lot (Ernst & Young LLP or any
other chosen accounting firm is referred to as the
“Accounting Firm”). Buyer will pay one-half, and
Sellers will pay one-half of the fees and expenses of the
Accounting Firm. The Accounting Firm will act as a neutral
arbitrator and, to the extent GAAP leaves room for discretion, will
exercise that discretion independently, but within the range of the
differences between the Parties. Buyer and Sellers Representative
each will provide the Accounting Firm with all data and documents
relevant to the determinations to be made by it, and copies of all
materials provided to the Accounting Firm will simultaneously be
provided to all Parties. Neither Buyer nor Sellers will meet or
discuss any substantive matters with the Accounting Firm without
the other Parties or their Representatives present or having the
opportunity following at least three business days notice to be
present, either in person or by telephone. Prior to making a final
determination, the Accounting Firm will have the power to require
any Party to provide to it and the other Parties such Books and
Records and other information it deems relevant to the resolution
of the dispute, and to require any Party to answer questions that
it deems relevant to the resolution of the dispute. The Accounting
Firm will revise the Closing Date Debt Statements to reflect its
resolution under Section 1.3 of all disputed matters,
and its resolution will be final, conclusive and binding on the
Parties.
(h) Sellers Representative will be
permitted to review and make copies of all workpapers, schedules
and calculations used in determining the Deferred Payment Amount
and the overdue accounts receivable set forth in Schedule
1.2(b) and to otherwise have access to and be permitted to make
copies of such books and records as he or she may reasonably need
to determine the accuracy of such calculations.
4
Section 1.4.
Closing . The
consummation of the transactions contemplated by this Agreement
(the “Closing”) are taking place at 10:00 a.m. local
time on October 12, 2006 (the “Closing Date”). The
Closing Date will be deemed effective as of the start of business
on the Closing Date.
Section 1.5. Deliveries at
the Closing .
|
|
(a)
|
At the Closing,
Buyer will deliver to Sellers:
|
(i) the Initial Payment;
(ii) the Escrow Agreement, duly
executed by Buyer, and evidence that the escrow under the Escrow
Agreement has been fully funded in accordance with
Section 1.2(b) ;
(iii) payment in full of the
promissory note referenced in Section 1.5(b)(xii)
below; and
(iv) any and all other agreements,
certificates, instruments and documents as may be reasonably
required of Buyer under this Agreement.
|
|
(b)
|
At the Closing,
Sellers will deliver to Buyer:
|
(i) stock certificates representing
the Shares duly endorsed in blank or accompanied by irrevocable
stock powers duly endorsed in blank, in either case sufficient to
transfer the Shares to Buyer free and clear of all
Encumbrances;
(ii) the Escrow Agreement, duly
executed by Sellers Representative;
(iii) mutual releases, in forms
reasonably acceptable to Buyer, duly executed by the Company and
each director and officer of the Company and the Subsidiaries and
resignations of each director and the following officers: Douglas
S. Soifer and Paul Oster;
(iv) mutual releases of the Company
and the Subsidiaries, in forms reasonably acceptable to Buyer, duly
executed by the Company and each Seller, Pullman Industries
IC-DISC, Inc. and TMW Enterprises Inc. (except with respect to the
fees to be paid post-Closing under Sections 4.5 and
4.14 ) or any Affiliate to which management or other fees
have been paid by the Company or any Subsidiary;
(v) a legal opinion of Honigman
Miller Schwartz and Cohn LLP, in the form attached as Exhibit
1.5(b)(v) ;
(vi) copies of all consents (if
applicable) and estoppel certificates, in forms reasonably
acceptable to Buyer, duly executed by each lessor of each Real
Property Lease;
5
(vii) evidence of the release of all
Encumbrances, other than Permitted Encumbrances, on the property
and assets of the Company and the Subsidiaries;
(viii) bank-payoff letters and
related Encumbrance discharges with respect to indebtedness to
JPMorgan Chase (“JPMC Debt”), the form of which payoff
letter is attached as Exhibit 1.5(b)(viii) ;
(ix) evidence that all patents used
by the Company or a Subsidiary and invented by an employee of the
Company or a Subsidiary or on behalf of the Company or a Subsidiary
have been validly assigned to the Company or a
Subsidiary;
(x) affirmation that all loans by
the Company or any Subsidiary to any officer or director or former
officer or director of the Company or any Subsidiary have been paid
in full;
(xi) copy of a quit claim deed
transferring the Company’s real property in Bloomingdale,
Michigan ( located at CR 388, Bloomingdale, Michigan, as
more fully described in Item 3 of Schedule 2.8(a) ) to
Bloomingdale Holdings LLC, a newly formed limited liability company
owned by the Company, and evidence of the distribution of all of
the outstanding membership interests in such limited liability
company to Sellers or their designee(s), in form reasonably
acceptable to Buyer;
(xii) evidence of the distribution
by the Company, immediately prior to Closing, of a $4,000,000
promissory note to Sellers and surrender of such promissory note
against the payment described in Section 1.5(a)(iii)
;
(xiii) except for the rights and
obligations set forth in the Pullman IC-DISC Stock Purchase
Agreement and as otherwise set forth in Exhibit 4.14 ,
evidence of termination of all of the Company’s or any
Subsidiaries’ commission and similar agreements with Pullman
Industries IC-DISC, Inc. from and after the Closing
Date;
(xiv) evidence of termination of the
employment agreement between any Mexican Subsidiary and Ruiz Mateos
and the transfer to Pullman de Mexico and Pullman de Puebla of all
equity interest of Ruiz Mateos in any of the Mexican Subsidiaries
for payment not to exceed $275,000 from existing cash of one or
more of the Mexican Subsidiaries, and a release of the Company and
the Subsidiaries, in form reasonably acceptable to Buyer, duly
executed by Mr. Mateos;
(xv) evidence that the terms of the
indebtedness of WLP Properties S. de R.L. de C.V. to TMW
Enterprises de Juarez, S.A. de C.V., TMW Enterprises de Mexico,
S.A. de C.V. and TMW Enterprises de Torreon, S.A. de C.V. have been
amended to Buyer’s satisfaction;
6
(xvi) a consent of GE CF Mexico,
S.A. de C.V. to the transactions contemplated by this Agreement and
waiver of any default or event of default arising
therefrom;
(xvii) evidence of the settlement of
Jorge Suarez Gomez v. Linde Pullman de Queretaro, S.A. de CV.;
and
(xviii) any and all other
agreements, certificates, instruments and documents as may be
reasonably required of Sellers, or any of them, under this
Agreement.
(c) At the Closing Buyer, on behalf
of the Company, will cause the JPMC Debt to be paid and discharged
and will provide replacement letters of credit in respect of the
JPMorgan Chase letters of credit set forth on Schedule
2.12(a)(iii) .
ARTICLE 2
REPRESENTATIONS AND WARRANTIES OF
SELLERS
Sellers, jointly and severally, make
the following representations and warranties to Buyer to induce
Buyer to enter into this Agreement and the other Transaction
Documents and consummate the transactions contemplated hereby and
thereby. These representations and warranties will survive the
Closing for the periods specified in Section 7.1
.
Section 2.1. Organization;
Capitalization; Ownership .
(a) The Company and each Subsidiary
is a corporation or limited liability company, as applicable, duly
organized, validly existing and in good standing under the
applicable Legal Requirements of the jurisdiction of its
organization. Copies of the Organizational Documents for the
Company and each Subsidiary have been provided to Buyer. The
Company and each Subsidiary has the requisite corporate or limited
liability company power and authority, as the case may be, to
conduct the Business as it is now being conducted, to own and use
the properties and assets that it purports to own and use and to
perform its obligations under the Applicable Contracts. The Company
and each Subsidiary is duly qualified to do business as a foreign
corporation and is in good standing in each state or other
jurisdiction in which either the ownership or use of the properties
owned or used by it or the nature of the activities conducted by it
requires such qualification, as identified on Schedule
2.1(a) .
(b) The authorized capital stock of
the Company consists of 7,000,000 shares of common stock, no par
value per share, of which 6,000,000 shares (the
“Shares”) are issued and outstanding. All of the Shares
were validly issued, are fully paid and nonassessable and were not
issued in violation of any preemptive or similar rights of any
Person. Except as provided on Schedule 2.1(b ), there are no
outstanding Contracts that require any Seller or the Company to
sell or issue any capital stock or other securities of the Company,
including any securities convertible into or exchangeable for any
capital stock or other securities of the Company. Except as
provided on Schedule 2.1(b) , there is no outstanding
subscription, option, warrant or other right, call or commitment to
issue, or any obligation or commitment to purchase, any capital
stock or other securities of the Company or any securities
convertible into or exchangeable for any capital stock or other
securities of the Company.
7
(c) Each Seller owns, beneficially
and of record, his, her or its Shares free and clear of all
Encumbrances, and Sellers collectively own, beneficially and of
record, all outstanding Shares. Each Seller owns the number of
Shares set forth next to his, her or its name on Schedule
2.1(c) . Except as set forth on Schedule 2.1(c) , no
Seller owns his, her or its Shares jointly with any other Person,
and no other Person has any right to consent to or vote upon the
transactions contemplated by this Agreement or any other
Transaction Document. At the Closing, each Seller will transfer to
Buyer valid title to all of the Shares free and clear of all
Encumbrances.
(d) Schedule 2.1(d) sets
forth the authorized, issued and outstanding capital stock or other
equity securities, as applicable, of each Subsidiary. All of the
capital stock or other equity securities of each Subsidiary were
validly issued, are fully paid and nonassessable and were not
issued in violation of any preemptive or similar rights of any
Person. There are no outstanding Contracts that require any Seller,
the Company or any Subsidiary to sell or issue any capital stock or
other equity securities of any Subsidiary, including any securities
convertible into or exchangeable for any capital stock or other
equity securities of a Subsidiary. There is no outstanding
subscription, option, warrant or other right, call or commitment to
issue, or any obligation or commitment to purchase, any capital
stock or other equity securities of a Subsidiary or any securities
convertible into or exchangeable for any capital stock or other
equity securities of a Subsidiary. Except for the Subsidiaries,
neither the Company nor any Subsidiary owns, or has any right to
acquire, any equity interest or other equity securities in any
other Person. The Company or a Subsidiary owns, beneficially and of
record, all of the outstanding capital stock or other equity
securities of each Subsidiary free and clear of all
Encumbrances.
Section 2.2. Financial
Statements and Financial Matters .
(a) Copies of the audited
consolidated financial statements of the Company, Pullman
Industries of Indiana, Inc. and Pullman Investments, LLC, at and
for the fiscal years ended December 31, 2005,
December 31, 2004 and December 31, 2003 are attached to
Schedule 2.2(a) (the “Financial Statements”).
Also attached to Schedule 2.2(a) are copies of the
unaudited consolidated interim balance sheets and interim
statements of income of the Company and Pullman Industries of
Indiana, Inc. at and for the month-ended August 27, 2006 (the
“Interim Financial Statements”). The Interim Financial
Statements include the consolidated balance sheet of the Company
and Pullman Industries of Indiana, Inc., at August 27, 2006
(the “Balance Sheet”). The Financial Statements and
Interim Financial Statements (subject, in the case of the Interim
Financial Statements, to normal year end adjustments and the
absence of footnotes thereto which, if presented would not differ
materially from those included in the Financial Statements) are
accurate and complete in all material respects and, except as set
forth in Schedule 2.2(a) , present fairly the financial
condition of the Company and Pullman Industries of Indiana, Inc.
(and in the case of the Financial Statements, Pullman Investments,
LLC), at the dates indicated and their results of operations for
the periods then ended. The Financial Statements and Interim
Financial Statements were prepared in accordance with GAAP
(subject, in the case of the Interim Financial Statements, to
normal recurring year-end adjustments and any other adjustments
described therein, the effect of which would not individually or in
the aggregate have a Company Material Adverse Effect, and the
absence of footnotes thereto which,
8
if presented would not differ materially from
those included in the Financial Statements). Each of Pullman AG,
Zug and Pullman Investments LLC are holding companies that are not
currently engaged in business operations, and, except as set forth
on Schedule 2.2(a) , neither of them has any liabilities or
assets other than the stock of their respective subsidiaries as set
forth on Schedule 2.1(d) and, in the case of Pullman AG,
Zug, certain Intellectual Property Assets described on Schedule
2.9(c) .
(b) Except as set forth on
Schedule 2.2(b) and except for (i) executory
obligations under Applicable Contracts and (ii) liabilities
expressly set forth in the Schedules to this Agreement, neither the
Company nor any U.S. Subsidiary has any liabilities or obligations
of any nature (whether known or unknown, absolute, accrued,
contingent or otherwise), required to be reflected on a balance
sheet (or in the notes thereto) in accordance with GAAP, except for
(A) liabilities or obligations expressly reflected or reserved
against in the Balance Sheet, and (B) balance sheet
liabilities incurred in the Ordinary Course of Business since the
date of the Balance Sheet.
(c) All accounts receivable of the
Company and the U.S. Subsidiaries as of the Closing Date (the
“Accounts Receivable”) will represent only valid
obligations due to the Company or a U.S. Subsidiary arising from
bona fide arm’s length transactions actually made by the
Company or a U.S. Subsidiary in the Ordinary Course of Business and
are not in dispute. All of the Tooling Receivables were outstanding
as of September 30, 2006, and, if collected, will be handled
as set forth in Section 1.2(c) and Exhibit
1.2(c) .
(d) Except for obsolete items and
items below standard quality, all of which have been written off or
written down to net realizable value on the Balance Sheet giving
effect to any inventory related reserves set forth on the Balance
Sheet, all of the inventory of the Company and the U.S.
Subsidiaries as of the Closing Date will (i) consist of
inventory manufactured or acquired in bona fide transactions in the
Ordinary Course of Business and (ii) be of a quality and
quantity usable and salable in the Ordinary Course of Business. All
inventories of the Company and the U.S. Subsidiaries not written
off are reflected in the Financial Statements and Interim Financial
Statements at the lower of cost or market on a first in, first out
basis, net of any reserves on the Balance Sheet. As of the Closing
Date, the quantities of each item of inventory (whether raw
materials, work-in-process or finished goods) of the Company and
the U.S. Subsidiaries will not be excessive, but will be reasonable
in the circumstances of the Business. All work-in-process inventory
of the Company or a U.S. Subsidiary constitutes items in process of
production pursuant to Contracts entered into in the Ordinary
Course of Business, from customers in bona fide arms length
transactions. All work in process inventory of the Company or a
U.S. Subsidiary is of a quality ordinarily produced in accordance
with the requirements of the orders to which such work in process
is identified.
(e) Except as set forth in
Schedule 2.2(e) , neither the Company nor any U.S.
Subsidiary has any outstanding indebtedness to any Seller or any
Related Person, and no Seller or any Related Person (other than the
Mexican Subsidiaries) has any outstanding indebtedness to the
Company or a U.S. Subsidiary.
9
(f) The Company received an annual
management review by Plante & Moran, PLLC containing a
certification of the internal controls of the Company, a copy of
which has been provided to Buyer.
(g) The amount accrued as a
liability on the Company’s September 30, 2006
consolidated balance sheet attached as Exhibit 8.2 with respect to
the Pullman Industries, Inc. Amended and Restated 2001 Equity
Participation Plan were accrued in accordance with such plan and in
a manner consistent with past practice.
Section 2.3. Books and
Records . The Books and
Records of the Company and the U.S. Subsidiaries, all of which have
been made available to Buyer, are complete and correct in all
material respects and have been maintained in accordance with sound
business practices. All of the Books and Records will be in the
possession of the Company or a U.S. Subsidiary, as applicable. The
corporate minute book and stock records of the Company and each
U.S. Subsidiary, which have been furnished to Buyer for inspection,
are complete and correct in all material respects and accurately
reflect all material corporate action taken by the Company and the
respective U.S. Subsidiaries. The directors and officers of the
Company and each U.S. Subsidiary are listed in Schedule 2.3
.
Section 2.4.
Taxes .
(a) Schedule 2.4(a) contains
a list of states, territories and jurisdictions to which any Taxes
have been claimed to be, or are, payable by the Company or a U.S.
Subsidiary. All Tax Returns of the Company and each U.S. Subsidiary
required under applicable Legal Requirements to be filed prior to
the Closing Date have been filed within the times (including
extensions) and in the manner prescribed by applicable Legal
Requirements. The Company and each U.S. Subsidiary has paid, or
caused to be paid, all Taxes due and owing by it, whether or not
shown or required to be shown on a Tax Return, and the Company and
each U.S. Subsidiary has provided on the Balance Sheet a sufficient
reserve for the payment of all Taxes associated with their
respective business operations through the date thereof but not yet
due and payable by it. Taxes paid or provided for on the Balance
Sheet include all Taxes for which the Company or a U.S. Subsidiary
may be liable in their own right or as the transferee of the assets
of, or as successor to, any other Person as of such date. Neither
the Company nor any U.S. Subsidiary is responsible for the payment
of Taxes of another Person (other than the Company or a U.S.
Subsidiary) by reason of the application of Treas. Reg.
§1.1502-6 or other Legal Requirement.
(b) All Taxes required to have been
collected or withheld by the Company or a U.S. Subsidiary before
the Closing Date have been duly collected or withheld and, to the
extent required before the Closing Date, have been duly paid to the
proper Governmental Body. Except as set forth in Schedule
2.4(b) , all Tax deficiencies asserted in writing or, to
Sellers Knowledge verbally, by the IRS or other Governmental Body
against the Company or a U.S. Subsidiary have been paid or finally
settled and in the case of the Company and Pullman Industries of
Indiana, Inc., recorded on the Balance Sheet. Except as set forth
on Schedule 2.4(b) , there are no audits of or other
Proceedings pending with respect to any Tax Returns of the Company
or a U.S. Subsidiary, and there are no outstanding waivers of
statutes of limitations regarding any Taxes payable by the Company
or a U.S. Subsidiary.
10
(c) The Company and each U.S.
Subsidiary has delivered or made available to Buyer copies of
(i) all Tax Returns with respect to all open years, and all
amendments thereto, and (ii) all audit or examination reports
or written proposed adjustments (whether formal or informal)
received from any Governmental Body relating to any Tax Return. The
charges, accruals and reserves with respect to the Taxes on the
Balance Sheet are adequate under GAAP and are at least equal to the
aggregate Tax liability of the Company and the U.S. Subsidiaries
(including any other Person whose Tax liability the Company or a
U.S. Subsidiary may have any responsibility for).
(d) Since January 1, 2006, the
Company has validly elected to be treated as an “S
Corporation” under Sections 1361 and 1362 of the Code, and it
will continue to be so treated until the date immediately prior to
the Closing Date. Since January 1, 2006, Pullman Industries of
Indiana, Inc. has validly elected to be treated as a
“qualified Subchapter S Subsidiary” within the meaning
of Section 1361(b)(3), and it will continue to be so treated
until the date immediately prior to the Closing Date. Except as set
forth in Schedule 2.4(d) , neither the Company nor any U.S.
Subsidiary has (i) applied for any Tax ruling, (ii) in
the immediately preceding three years, entered into or is proposing
to enter into a Contract with any Governmental Body regarding
Taxes, (iii) filed an election under Section 338(g) or
Section 338(h)(10) of the Code (nor has a deemed election
under Section 338(e) of the Code occurred), (iv) made any
payments, or been a party to an Contract (including this
Agreement), that under any circumstances could obligate it to make
payments that will not be deductible because of Section 280G
of the Code, or (v) been a party to any Tax allocation or Tax
sharing Contract or similar arrangement, other than a Contract or
arrangement solely among the Company and the U.S. Subsidiaries or
certain of them. Neither the Company nor any U.S. Subsidiary is a
“United States real property holding corporation”
within the meaning of Section 897 of the Code.
(e) To Sellers’ Knowledge, the
gross amount of the Tax Refund Amount is approximately $1,400,000.
Sellers’ reasonable estimate of the Tax Refund Amount is set
forth on Schedule 2.4(e) .
(f) Pullman Industries Ltd. filed
its final Tax Returns as a foreign sales corporation for 2001 on or
before September 15, 2002 and all applicable statutes of
limitation with respect thereto have expired on or before
September 15, 2005. Pullman Industries Ltd. was properly
liquidated in 2005.
(g) Pullman Industries Ltd. claimed
no Tax benefits as a foreign sales corporation not permitted under
applicable Legal Requirements.
Section 2.5. Business
Operations .
(a) Except as set forth in
Schedule 2.5(a) , since December 31, 2005, (i) the
operations and affairs of the Company and each U.S. Subsidiary have
been conducted only in the Ordinary Course of Business and
(ii) no Restricted Event has occurred.
(b) No Seller, Related Person or any
of any of their respective Affiliates is an owner, shareholder,
creditor or agent of, or consultant or lender to, any Person
engaged in a business that acts as a supplier or purchaser of any
goods or services to or from the Company or any U.S. Subsidiary or
any part of which is in actual or potential competition with the
Company or any U.S. Subsidiary.
11
(c) Schedule 2.5(c)(1) sets
forth a list of the 10 largest customers and 10 largest suppliers
(by dollar volume) of the Company and the U.S. Subsidiaries,
collectively, in terms of sales or purchases for the eight months
ended August 27, 2006 and the 12 months ended
December 31, 2005. Except as set forth on Schedule
2.5(c)(2) , (i) neither the Company nor any U.S.
Subsidiary has received any written notice with respect to the
re-sourcing of any customer Contract or business, (ii) to
Sellers’ Knowledge no customer or supplier has expressly
informed the Company or any U.S. Subsidiary that it has any present
plan to discontinue any Contract or terminate its business
relationship with the Company or a U.S. Subsidiary, and
(iii) while customer programs are subject to market testing
from time to time, neither the Company nor any U.S. Subsidiary has
received written notice that any customer program is being market
tested. Since December 31, 2005, neither the Company nor any
U.S. Subsidiary has extended credit to any customer (including a
distributor) on terms or in amounts that are materially more
favorable than those extended in the past or otherwise materially
changed the terms of credit extended to any such customer outside
the Ordinary Course of Business. Since December 31, 2005,
neither the Company nor any U.S. Subsidiary has materially changed
its credit policies governing the extension of credit to
customers.
(d) Schedule 2.5(d) lists all
warranties applicable to products designed, developed,
manufactured, sold, to be sold or subject to a pending bid by the
Company or a U.S. Subsidiary. There are no claims outstanding
against the Company or any U.S. Subsidiary in excess of the
reserves established therefore on the Balance Sheet to return
products by reason of alleged overshipments, early or late
shipments, defective delivery, defective merchandise or otherwise,
and there is no Proceeding pending, or to Sellers’ Knowledge
Threatened, against the Company or a U.S. Subsidiary under any
product warranty. No product warranty claims have been asserted
against the Company or a U.S. Subsidiary within the past three
years.
(e) Neither the Company nor any U.S.
Subsidiary has received written notice of any, and there is no,
unresolved claim of personal injury, death or property or economic
damage, or any unresolved claim for injunctive relief in connection
with any product manufactured or sold by the Company or a U.S.
Subsidiary. There are no defects in design, construction or
manufacture of products sold or held in inventory for sale that
would adversely affect their performance or create an unusual risk
of injury to persons or property. Except as disclosed in
Schedule 2.5(e) , none of the Company’s or a U.S.
Subsidiary’s products has been the subject of any
replacement, field fix, retrofit, modification or recall campaign.
Such products have been designed and manufactured so as to meet and
comply sufficiently to avoid any Adverse Consequences arising from
a failure to comply with all governmental standards and applicable
purchase specifications currently in effect, and have received all
Governmental Authorization necessary to allow their sale and use.
No product liability claims have been asserted against the Company
or a U.S. Subsidiary within the past three years.
(f) Schedule 2.5(f) lists the
names, account numbers and locations of all banks and other
financial institutions at which the Company and each U.S.
Subsidiary has any account or safe deposit box and the names of all
Persons authorized to draft on or have access to any such accounts
or safe deposit box.
12
(g) None of the Company, any U.S.
Subsidiary, any Seller or, to Sellers’ Knowledge, any of
their respective Representatives, has in connection with the
Business (i) used any corporate or other funds of the Company
or a U.S. Subsidiary for unlawful contributions, payments, gifts or
gratuities, or made any unlawful expenditures relating to political
or administrative activity to officials of a Governmental Body or
to any other Person, or established or maintained any unlawful or
unrecorded funds in violation of any Legal Requirement, or
(ii) accepted or received any unlawful contributions,
payments, expenditures or gifts.
Section 2.6.
Employees .
(a) Schedule 2.6(a) contains,
as of a recent date specified therein, the following information
for each employee of the Company and each U.S. Subsidiary
(including, as designated thereon, each employee on leave of
absence or layoff status): name; job title; hire date; and current
compensation paid or payable on an annualized basis. Neither the
Company nor a U.S. Subsidiary has received notice that a Key
Employee intends to terminate his or her employment relationship
with the Company or a U.S. Subsidiary, as applicable. All Key
Employees of the Company and each U.S. Subsidiary are either U.S.
citizens or permanent resident aliens or are otherwise authorized
to be lawfully employed in the United States. Except as set forth
in Schedule 2.6(a) , each employee of the Company and each
U.S. Subsidiary is employed on an “at will” basis and
is terminable by the Company or the U.S. Subsidiary, as applicable,
without any penalty or severance obligation. A copy of the current
version of each policy manual and handbook provided to or governing
the employees of the Company and the U.S. Subsidiaries, and a copy
of the application forms currently being used by the Company and
the U.S. Subsidiaries in connection with the hiring of new
employees, has been provided to Buyer.
(b) Except as set forth in
Schedule 2.6(b) , neither the Company nor any U.S.
Subsidiary is now or in the past three years has been a party to
any collective bargaining or other similar labor Contract. A copy
of each such Contract has been provided to Buyer. Since
January 1, 2004, with respect to the Company or any U.S.
Subsidiary, there has not been, there is not now pending or
existing and to Sellers’ Knowledge there is not Threatened:
(i) any strike, slowdown, picketing, work stoppage, lockout,
union organizational activity or other labor dispute or Proceeding
(excluding routine labor grievances); (ii) any application,
written complaint or charge filed by any employee or union with any
Governmental Body or any grievance filed pursuant to a collective
bargaining agreement for which any Seller, the Company or a U.S.
Subsidiary has Knowledge or has received written notice or
(iii) any application or demand for recognition or
certification of a collective bargaining agent for which a Seller,
the Company or a U.S. Subsidiary has Knowledge or has received
written notice. Except as set forth on Schedule 2.6(b) ,
there is not currently, nor has there been in the past three years,
any internal investigation of any charge or complaint by any
employee of the Company or a U.S. Subsidiary alleging harassment,
discrimination or other employment conduct. All Legal Requirements
relating to the employees of the Company and each U.S. Subsidiary,
including Legal Requirements relating to terms of employment,
immigration and employment of illegal aliens, the payment of social
security and other payroll Taxes, the payment of employee wages and
benefits (including minimum wage and overtime pay) and Occupational
Safety and Health Law, have been complied with.
13
(c) Except as set forth in
Schedule 2.6(c) , neither the Company nor any U.S.
Subsidiary is a party to any Contract, with any present or former
director, officer, employee, agent or consultant with respect to
length, duration or conditions of employment or engagement (or the
termination thereof), salaries, bonuses, compensation, deferred
compensation, health Insurance, severance, any other form of
remuneration or otherwise, the obligations of which could be
asserted following the Closing against the Company, a U.S.
Subsidiary or Buyer.
(d) Neither the Company nor any U.S.
Subsidiary has effectuated a “mass layoff” (as defined
in the WARN Act) affecting any single site of employment (as
defined in the WARN Act), and neither the Company nor any U.S.
Subsidiary has engaged in layoffs or employment terminations
sufficient in number to trigger application of any similar state or
local Legal Requirement. None of the employees of the Company or a
U.S. Subsidiary will have suffered an “employment loss”
under the WARN Act in the six months prior to the Closing Date or
any similar state or local Legal Requirement in the twelve months
prior to the Closing Date.
(e) The Company has made all
required payments to its unemployment compensation reserve accounts
with the appropriate Governmental Bodies of the states or other
jurisdictions where it is required to maintain such accounts, and
each of such accounts has a positive balance.
Section 2.7. Employee
Benefit Plans .
(a) Schedule 2.7(a) sets
forth all Employee Benefit Plans. Copies of Employee Benefit Plans
and all Contracts relating to Employee Benefit Plans (including
descriptions of vacation, separation and other personnel policies)
have been provided to Buyer. Neither the Company nor any U.S.
Subsidiary is bound by any unwritten Employee Benefit Plan or
Contract relating to any Employee Benefit Plan.
(b) Except as set forth on
Schedule 2.7(b) , the Company and each U.S. Subsidiary has
timely complied with all obligations under the Employee Benefit
Plans (including, to the extent applicable, reporting, disclosure,
prohibited transaction, IRS qualification, ERISA and funding
obligations). Each Employee Benefit Plan, and the administration of
each Employee Benefit Plan, complies and has at all relevant times
complied with all applicable Legal Requirements, including the Code
and ERISA. No prohibited transaction within the meaning of
Section 406 of ERISA or Section 4975 of the Code for
which a statutory or administrative exemption does not exist has
occurred with respect to any Employee Benefit Plan.
(c) Each Employee Benefit Plan that
is intended to be qualified under Section 401(a) of the Code
has received a favorable determination or opinion letter from the
IRS as to its qualified status under the Code, and each Employee
Benefit Plan that is a funded welfare plan and whose trust is
intended to be exempt from federal taxation under
Section 501(a) of the Code has received recognition of
exemption from federal income taxation from the IRS. Nothing has
occurred since the date of such determination or recognition of
exemption that could adversely affect the qualification of such
Employee Benefit Plan or the Tax exempt status of any related
trust. Sellers have delivered to Buyer copies of the
following:
(i) the most recent determination or
opinion letter issued by the IRS with respect to each Employee
Benefit Plan that is intended to be qualified under
Section 401(a) and/or 501(a) of the Code; and
14
(ii) the two most recent Annual
Reports (IRS Forms 5500 series), including Schedules A and B, if
applicable, required to be filed with respect to each Employee
Benefit Plan.
(d) Neither the Company, a U.S.
Subsidiary nor any of their respective predecessors or Affiliates
has ever established, maintained or contributed to or otherwise
participated in, or has or has had an obligation to establish,
maintain, contribute to or otherwise participate in, or has any
obligation or liability in connection with, any Multi-Employer
Retirement Plan.
(e) Except as set forth in
Schedule 2.7(e) , neither the Company, a U.S. Subsidiary nor
any of their respective predecessors or Affiliates has any
obligation to provide post-retirement medical or other benefits to
any director, employee or agent or former director, employee or
agent or their survivors, dependents or beneficiaries, except as
may be required by Section 4980B of the Code or Part 6 of
Title I of ERISA or applicable Legal Requirements concerning
medical benefits continuation.
(f) Neither the Company, a U.S.
Subsidiary nor any of their respective predecessors or Affiliates
maintains or has maintained or has had any obligation to contribute
to a defined benefit plan as defined in Section 3(35) of
ERISA.
(g) There is no Proceeding pending
(other than routine claims for benefits) against or in respect of
any Employee Benefit Plan or the assets of any Employee Benefit
Plan. No civil or criminal action brought pursuant to the
provisions of Title I, Subtitle B, Part 5 of ERISA is pending, or
to Sellers’ Knowledge Threatened, against any fiduciary of
any Employee Benefit Plan. To Sellers’ Knowledge none of the
Employee Benefit Plans or any fiduciary thereof has been the direct
or indirect subject of an audit, investigation or examination by
any Governmental Body.
(h) No Contract or other obligation
exists to increase any benefits under any Employee Benefit Plan or
to adopt any new Employee Benefit Plan.
(i) Except as set forth in
Schedule 2.7(i) , the consummation of the transactions
contemplated by this Agreement will not (i) entitle any
current or former director or employee of the Company or any U.S.
Subsidiary to severance pay, unemployment compensation or any other
payment, except as expressly provided in this Agreement;
(ii) accelerate the time of payment or vesting, or increase
the amount, of compensation due to any director or employee or
former director or employee either under an Employee Benefit Plan
or otherwise; or (iii) result in any prohibited transaction
described in Section 406 of ERISA or Section 4975 of the
Code for which an exemption is not available.
(j) Neither the Company nor any U.S.
Subsidiary, with respect to any Employee Benefit Plan, is subject
to any Tax under Code Sections 4972 or 4979 or to any loss of Tax
deduction under Code Sections 162(m) and 280G.
15
(k) Except as set forth in
Schedule 2.7(k) , each Employee Benefit Plan that is subject
to the provisions of the Health Insurance Portability and
Accountability Act of 1996, as amended (“HIPAA”), has
complied with HIPAA in all material respects.
(l) With respect to the Pullman
Industries, Inc. Amended and Restated Equity Participation Plan
(the “EPP”), the committee designated to administer the
EPP pursuant to Section 1.4(e) of the EPP (the “EPP
Committee”) has not taken any action to terminate the EPP or
accelerate the vesting of any Units (as defined in the EPP) or
other benefits under the EPP. With respect to 2006, the EPP
Committee has not determined any benefits under the EPP, including
distributions or any value associated with the Units.
Section 2.8. Real
Property .
(a) The Company and each U.S.
Subsidiary has good and marketable fee simple title to or valid
leaseholds in all of the real property owned or used in connection
with the Business (“Real Property”), including all of
the Real Property reflected on the Balance Sheet. The Real Property
owned by the Company or a U.S. Subsidiary (“Owned Real
Property”) is not subject to any lease, tenancy, occupancy
Contract, license or option. Except as set forth in Schedule
2.8(a) , neither the Company nor any U.S. Subsidiary is a party
to or the beneficiary of any Tax abatement or similar agreement or
any Tax abatement or similar appeal in respect of any Real
Property. Except as set forth in Schedule 2.8(a) , neither
the Company nor any U.S. Subsidiary owns any interest in, nor have
they ever owned or had any interest in (other than a leasehold
interest in), any Real Property. All of the Real Property
identified as currently owned by the Company or a U.S. Subsidiary
on Schedule 2.8(a) is free and clear of all Encumbrances
other than Permitted Encumbrances.
(b) Schedule 2.8(b) contains,
with respect to all Real Property leased by the Company or a U.S.
Subsidiary, the term, base rent, any component of additional rent
and any option to purchase, and lists each lease, sublease, license
and occupancy Contract concerning Real Property to which the
Company or any U.S. Subsidiary is a signatory or by which any of
them are bound or affected (individually a “Real Property
Lease” and collectively the “Real Property
Leases”). A copy of each Real Property Lease has been
provided to Buyer. The Company or a U.S. Subsidiary has a valid and
binding leasehold interest in each of the Real Property Leases.
None of the Company or any U.S. Subsidiary, or to Sellers’
Knowledge, any other Person, is in default in respect of its
obligations or liabilities pertaining to any Real Property
Lease.
(c) Neither the Company nor any U.S.
Subsidiary uses Real Property other than the Real Property
identified on Schedule 2.8(a) and Schedule 2.8(b) .
All buildings or improvements used by the Company or a U.S.
Subsidiary lie wholly within the boundaries of the applicable Real
Property and do not encroach on any easement or property owned by
another Person, and no building or improvement owned or used by
another Person encroaches on any property that the Company or a
U.S. Subsidiary owns or uses or on any easement the benefit of
which runs to the Company or a U.S. Subsidiary to the lessor under
any Real Property Lease. The Real Property and the use of the Real
Property by the Company and each U.S. Subsidiary complies, with all
Applicable Contracts and applicable Legal Requirements. To
Sellers’ Knowledge, there are no material ground subsidences
or slides on or affecting any Real Property. None of the Real
Property is the subject of any condemnation action and, to
Sellers’ Knowledge, there is no
16
proposal under consideration by any Governmental
Body to take or use any of the Real Property. All such Real
Property has access on a public way sufficient for the current use
of the Real Property by the Company or a U.S. Subsidiary, as
applicable. Neither the Company nor a U.S. Subsidiary is in
violation of any zoning regulation, building restriction,
restrictive covenant, ordinance or other Legal Requirement relating
to any Real Property. The Real Property, and all components
thereof, including the electrical systems, mechanical systems,
roof, plumbing and fire/safety systems are in good working order
and will perform the work or function for which
intended.
Section 2.9. Other
Properties and Assets .
(a) All other properties and assets
(in addition to Owned Real Property) owned by the Company or any
U.S. Subsidiary are free and clear of all Encumbrances other than
Permitted Encumbrances. Except as set forth on Schedule
2.9(a) , none of the Company’s or a U.S.
Subsidiary’s properties or assets is subject to any
restrictions with respect to the transferability thereof, and the
Company’s and each U.S. Subsidiary’s title thereto will
not be affected in any way by the transactions contemplated by this
Agreement. Schedule 2.9(a) lists each lease by the
Company or a U.S. Subsidiary of property and assets (other than
Real Property), including the commencement and termination dates of
each such lease (collectively, “Personal Property
Leases”). A copy of each Personal Property Lease has been
provided to Buyer. All properties and assets owned or leased by the
Company or a U.S. Subsidiary will be in the possession of the
Company or a U.S. Subsidiary on the Closing Date
.
(b) The buildings, structures and
equipment owned, leased or used by the Company or a U.S.
Subsidiary: (i) are in good operating condition and repair,
reasonable wear and tear excepted, (ii) are adequately
serviced by all required utilities and are adequate for the uses to
which they are being put; and (iii) to Sellers’
Knowledge are free of material defects; and (iv) are
sufficient for the continued conduct of the Business after the
Closing in substantially the same manner as conducted before the
Closing. The Company and each U.S. Subsidiary has maintained their
buildings, structures and equipment in accordance with their
established maintenance schedules in all material
respects.
(c) Schedule 2.9(c) sets
forth: (i) all Intellectual Property Assets owned by the
Company or a U.S. Subsidiary (“Company Intellectual Property
Assets”); (ii) all Intellectual Property Assets used but
not owned by the Company or a U.S. Subsidiary (“Other
Intellectual Property Assets”); and (iii) a list of all
Contracts relating to Intellectual Property Assets to which the
Company or a U.S. Subsidiary is a party or by which the Company or
a U.S. Subsidiary is bound or affected (copies of which have been
provided to Buyer), including: (1) all of the Company’s
or any U.S. Subsidiaries’ Contracts for the license of
Intellectual Property Assets; and (2) all royalty fee
arrangements to which the Company or any U.S. Subsidiary is bound.
Schedule 2.9(c) also lists (i) all disputes involving
the Company or any U.S. Subsidiary relating to any Contracts
relating to any Intellectual Property Assets or royalty fee
arrangements in the last three years; and (ii) all
improvements made or claimed to be made by the Company or any U.S.
Subsidiary to any Other Intellectual Property Asset.
(d) On and following the Closing
Date, the Company or a U.S. Subsidiary will own the entire right,
title and interest in and to Company Intellectual Property Assets
free and clear of
17
all Encumbrances other than Permitted
Encumbrances. Except as set forth in Schedule 2.9(d) , on
and following the Closing Date, the Company or a U.S. Subsidiary
will have the right to continue to use the Company Intellectual
Property Assets and Other Intellectual Property Assets without
payment or other liability to any Person. Neither the Company nor
any U.S. Subsidiary has infringed or unlawfully used any
Intellectual Property Asset of any other Person. To Sellers’
Knowledge there is no infringement of or unlawful use by any other
Person of any of the Company Intellectual Property Assets. None of
the Company Intellectual Property Assets is subject to any pending,
or to Sellers’ Knowledge Threatened, Proceeding, and none of
Company Intellectual Property Assets or Other Intellectual Property
Assets is subject to any outstanding Order restricting use by the
Company or a U.S. Subsidiary (or by Buyer or an Affiliate of Buyer
following the Closing) of that Intellectual Property Asset. The
Company Intellectual Property Assets and the Other Intellectual
Property Assets are all of those necessary for the operation of the
Business as now conducted and are sufficient in form and quality so
that, following the Closing, Buyer, the Company and each U.S.
Subsidiary will be able to continue to operate the Business as now
conducted.
Section 2.10.
Litigation . Except as
set forth in Schedule 2.10 , there is no Proceeding
(excluding employee grievances and routine workers’
compensation Proceedings in the Ordinary Course of Business) or
Order pending with respect to the Company, any U.S. Subsidiary, the
Business or any of the properties or assets owned or used by the
Company or a U.S. Subsidiary. To Sellers’ Knowledge, no such
Proceeding or Order has been Threatened.
Section 2.11. Authorization
and Enforceability; No Conflict .
(a) Each Seller has the requisite
capacity, power and authority to enter into and perform the
Transaction Documents to which such Seller is a party and to carry
out the transactions contemplated by the Transaction Documents to
which he, she or it is a party (including any Transaction Document
executed by Sellers Representative on each Seller’s behalf).
Each Transaction Document to which a Seller is a signatory or to
which Sellers Representative has signed on each Seller’s
behalf is binding upon such Seller and is enforceable against such
Seller in accordance with its terms, except as may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium and
similar laws affecting creditors’ rights and remedies
generally.
(b) Except as set forth in
Schedule 2.11(b) , the execution, delivery and performance
of the Transaction Documents and the consummation of the
transactions contemplated thereby will not (i) contravene any
Organizational Documents of the Company or a Subsidiary or result
in a breach of any provision of, or constitute a default under, any
Applicable Contract, or to Seller’s Actual Knowledge a
Mexican Contract which would have a Mexican Company Adverse Effect;
(ii) violate any Legal Requirement or Order or give any
Governmental Body the right to revoke, withdraw, suspend, cancel,
terminate or modify any Governmental Authorization;
(iii) result in the imposition of any Tax on the Company, a
Subsidiary or Buyer; (iv) result in the acceleration of any
liability of the Company or a Subsidiary, or adversely modify terms
of any such liability; (v) result in any Encumbrance being
created or imposed upon any property or asset of the Company or a
Subsidiary; or (vi) except for filings under the HSR Act,
require any authorization, consent, approval, exemption or other
authority or notice to any Governmental Body. The representations
and warranties set forth in clauses (ii)-(vi) in the preceding
sentence
18
and those set forth in the succeeding sentence,
as they relate to the Mexican Subsidiaries, are provided only on
the basis of Sellers’ Actual Knowledge and each shall only be
deemed Breached if any Breach or Breaches in the aggregate give
rise to a Mexican Company Material Adverse Effect. All consents,
approvals or authorizations of, or declarations, filings or
registrations with, any Person required (including those required
under the terms of any Applicable Contract or to Sellers’
Actual Knowledge any Mexican Contract to avoid a breach or default
thereunder) in connection with the execution, delivery or
performance of the Transaction Documents by Sellers or the
consummation of the transactions contemplated thereby are set forth
in Schedule 2.11(b) and, except as set forth in Schedule
2.11(b) , have been obtained or made, as applicable, by
Sellers.
Section 2.12. Applicable
Contracts; Insurance .
(a) All of the following Applicable
Contracts of the Company and the U.S. Subsidiaries are listed on
Schedule 2.12(a) and copies of which have been provided
to Buyer:
(i) Any power of
attorney;
(ii) Any joint venture or similar
Contracts;
(iii) Any loan agreement, promissory
note, letter of credit, or other evidence of indebtedness as a
signatory, and any guarantee by the Company or a U.S. Subsidiary of
the payment or performance of any Person, Contract to indemnify any
Person or act as a surety or other Contract to be contingently or
secondarily liable for the obligations of any Person;
(iv) Any broker, sales
representative, vendor, distributor or similar Contract;
(v) Any Contract under which the
Company or a U.S. Subsidiary has made or received payments in
excess of $100,000 in the current fiscal year or anticipates making
or receiving payments in excess of $100,000 in the current fiscal
year (other than purchase orders that have been fulfilled on or
prior to the Closing Date);
(vi) Any Contract prohibiting or
restricting the Company or a U.S. Subsidiary from competing in any
business or geographical area or from soliciting any customer or
purchasing from any supplier, or otherwise restricting it from
carrying on its business anywhere in the world, or any Contract
requiring the Company or a U.S. Subsidiary to assign any interest
in any trade secret, proprietary information or Intellectual
Property Asset;
(vii) Any Contract that is so
burdensome as to cause a Company Material Adverse Effect;
and
(viii) Any other Contracts with
value in excess of $200,000 not included elsewhere in the
Disclosure Schedule (other than purchase orders that have been
fulfilled on or prior to the Closing Date).
19
(b) Each Applicable Contract
(including each Contract required to be provided elsewhere in this
Article 2 ) is in full force and effect and is valid and
enforceable in accordance with its terms. The Company and each U.S.
Subsidiary, and to Sellers’ Knowledge, each other Person that
is a party to an Applicable Contract, has complied and is complying
with the terms of each Applicable Contract sufficiently to avoid
any breach or default thereunder, and no event has occurred or
circumstance exists that (with or without notice or lapse of time)
would contravene, conflict with or result in a violation or breach
of, or give the Company or a U.S. Subsidiary, or to Sellers’
Knowledge any other Person, the right to declare a default under,
any Applicable Contract.
(c) Schedule 2.12(c) sets
forth a list of all of the policies of Insurance for the Company
and the U.S. Subsidiaries or covering any of their respective
properties, assets, directors, employees, products or operations,
and for each policy indicates: (i) the name of the insurer;
(ii) the amount of coverage; (iii) the type of Insurance;
(iv) the policy number; (v) the expiration date; and
(vi) all pending claims under the policy (other than routine
employee claims for benefits under the Company’s health and
welfare plans in the Ordinary Course of Business). Copies of each
such policy have been provided to Buyer. Each such policy of
Insurance is outstanding and will be in full force and effect and
will remain in full force through the Closing Date. All premiums
with respect to such policies are currently paid, and all duties of
the insureds under such policies have been fully discharged.
Neither the Company nor a U.S. Subsidiary has been refused
Insurance by any carrier to which it has applied for Insurance
within the past five years. In the past five years, all products
liability and general liability Insurance policies maintained by or
for the benefit of the Company have been “occurrence”
policies and not “claims made” policies.
Section 2.13. Permits and
Licenses; Compliance with Legal Requirements
.
(a) All Governmental Authorizations
necessary for the Company and the U.S. Subsidiaries to carry on the
Business as now conducted are set forth in Schedule 2.13(a)
, have been timely obtained, are in full force and effect and have
been complied with. Other than in respect of any filings required
by the HSR Act, no Governmental Authorization is required, nor will
any Governmental Authorization be voided, nullified or impacted by
or in connection with the transactions contemplated by this
Agreement. All fees and charges incident to the Company’s or
a U.S. Subsidiary’s Governmental Authorizations have been
fully paid and are current, and no suspension or cancellation of
any Governmental Authorization has been Threatened. The Company and
each U.S. Subsidiary has filed all reports and returns required to
be filed with any Governmental Body, and all such reports and
returns were complete and correct in all material respects when
filed.
(b) None of the Company, any U.S.
Subsidiary or any of the properties and assets owned or used by the
Company or any U.S. Subsidiary is subject to, nor to Sellers’
Knowledge has the Company or a U.S. Subsidiary been Threatened
with, any Adverse Consequence as the result of a failure to comply
with any Legal Requirement. The Company and each U.S. Subsidiary is
now, and during all applicable statutory of limitation periods has
been, in compliance with all applicable Legal
Requirements.
20
Section 2.14. Environmental
Matters .
(a) Except as set forth in
Schedule 2.14(a) : (i) the Company and each U.S.
Subsidiary is and during all applicable statute of limitation
periods has been in compliance with all applicable Environmental
Laws; (ii) the Company and each U.S. Subsidiary possesses all
Governmental Authorizations required under applicable Environmental
Laws and has complied, and is complying with the terms and
conditions thereof; and (iii) the Company and each U.S.
Subsidiary is in compliance with all notification, reporting and
registration provisions under applicable Environmental
Laws.
(b) Neither the Company nor any U.S.
Subsidiary has received any written communication, whether from a
Governmental Body, citizens group, employee or otherwise, alleging
that the Company or a U.S. Subsidiary is not in full compliance
with any Environmental Laws. All Governmental Authorizations and
compliance schedules currently held by the Company or a U.S.
Subsidiary pursuant to any Environmental Laws are identified in
Schedule 2.14(b) , and copies thereof have been provided to
Buyer.
(c) Except as set forth on
Schedule 2.14(c) , there is no Environmental Liability
existing or, to Sellers’ Knowledge, Threatened against the
Company or any U.S. Subsidiary or against any Person whose
liability for any Environmental Liability the Company or a U.S.
Subsidiary has or may have retained or assumed, either
contractually or by operation of applicable Legal Requirements.
Except as set forth on Schedule 2.14(c) , there is no past
or present action, activity, circumstance, condition, event or
incident, including the release, emission, discharge, presence,
treatment or disposal of any Hazardous Substance or Material, that
would form the basis for any Environmental Liability of the
Company, a U.S. Subsidiary or of any Person whose responsibility
for any such Environmental Liability the Company or a U.S.
Subsidiary has or may have retained or assumed, either
contractually or by operation of applicable Legal
Requirements.
(d) Except as set forth on
Schedule 2.14(d) : (i) none of the Real Property
is listed on, or to Sellers’ Knowledge is being considered
for listing on, any list of contaminated sites maintained under any
Environmental Law or is subject to, or to Sellers’ Knowledge
is being considered for enforcement action under, any Environmental
Law; (ii) none of the Real Property has been designated as an
area under the control of any conservation authority;
(iii) the Real Property is free of the presence of any waste
or any Hazardous Substance or Material in, on or under the
Environment in a quantity or concentration that could result in any
Environmental Liability; (iv) no underground storage tanks,
receptacles or other similar containers or depositories are, or
ever have been, present on the Real Property; (v) none of the
buildings, building components, structures or improvements owned,
leased or used by the Company or a U.S. Subsidiary is constructed
in whole or in part of any material (including asbestos, except to
the extent properly encapsulated in accordance with Environmental
Laws) that releases or may release any substance, whether gaseous,
liquid or solid, that may give rise to any Environmental Liability;
(vi) neither the Business nor its properties or assets
constitutes or has constituted a nuisance and no claim of nuisance
ha